miRNA | gene name | experiments | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hsa-miR-200c-3p | Vldlr |
|
||||||||||||||||
hsa-miR-200c-3p | Reln |
|
||||||||||||||||
hsa-miR-200c-3p | TUBB3 |
|
||||||||||||||||
hsa-miR-200c-3p | BMI1 |
|
||||||||||||||||
hsa-miR-200c-3p | GEMIN2 |
|
||||||||||||||||
hsa-miR-200c-3p | BAP1 |
|
||||||||||||||||
hsa-miR-200c-3p | EP300 |
|
||||||||||||||||
hsa-miR-200c-3p | FN1 |
|
||||||||||||||||
hsa-miR-200c-3p | ZFPM2 |
|
||||||||||||||||
hsa-miR-200c-3p | JAG1 |
|
||||||||||||||||
hsa-miR-200c-3p | PTPN13 |
|
||||||||||||||||
hsa-miR-200c-3p | RNF2 |
|
||||||||||||||||
hsa-miR-200c-3p | RCOR3 |
|
||||||||||||||||
hsa-miR-200c-3p | BRD7 |
|
||||||||||||||||
hsa-miR-200c-3p | ACVR2B |
|
||||||||||||||||
hsa-miR-200c-3p | MSN |
|
||||||||||||||||
hsa-miR-200c-3p | NTRK2 |
|
||||||||||||||||
hsa-miR-200c-3p | ERRFI1 |
|
||||||||||||||||
hsa-miR-200c-3p | CCNE2 |
|
||||||||||||||||
hsa-miR-200c-3p | XIAP |
|
||||||||||||||||
hsa-miR-200c-3p | BCL2 |
|
||||||||||||||||
hsa-miR-200c-3p | TIMP2 |
|
||||||||||||||||
hsa-miR-200c-3p | FBLN5 |
|
||||||||||||||||
hsa-miR-200c-3p | VEGFA |
|
||||||||||||||||
hsa-miR-200c-3p | NCAM1 |
|
||||||||||||||||
hsa-miR-200c-3p | IKBKB |
|
||||||||||||||||
hsa-miR-200c-3p | FLT1 |
|
||||||||||||||||
hsa-miR-200c-3p | KLF9 |
|
||||||||||||||||
hsa-miR-200c-3p | TBK1 |
|
||||||||||||||||
hsa-miR-200c-3p | PMAIP1 |
|
||||||||||||||||
hsa-miR-200c-3p | NTF3 |
|
||||||||||||||||
hsa-miR-200c-3p | LPAR1 |
|
||||||||||||||||
hsa-miR-200c-3p | EDNRA |
|
||||||||||||||||
hsa-miR-200c-3p | RHOA |
|
||||||||||||||||
hsa-miR-200c-3p | KLHL20 |
|
||||||||||||||||
hsa-miR-200c-3p | PTPRD |
|
||||||||||||||||
hsa-miR-200c-3p | ELMO2 |
|
||||||||||||||||
hsa-miR-200c-3p | ERBIN |
|
||||||||||||||||
hsa-miR-200c-3p | WDR37 |
|
||||||||||||||||
hsa-miR-200c-3p | VAC14 |
|
||||||||||||||||
hsa-miR-200c-3p | TCF7L1 |
|
||||||||||||||||
hsa-miR-200c-3p | RASSF2 |
|
||||||||||||||||
hsa-miR-200c-3p | HOXB5 |
|
||||||||||||||||
hsa-miR-200c-3p | RIN2 |
|
||||||||||||||||
hsa-miR-200c-3p | KLF11 |
|
||||||||||||||||
hsa-miR-200c-3p | SEPT7 |
|
||||||||||||||||
hsa-miR-200c-3p | SHC1 |
|
||||||||||||||||
hsa-miR-200c-3p | ZNF416 |
|
||||||||||||||||
hsa-miR-200c-3p | ILF3 |
|
||||||||||||||||
hsa-miR-200c-3p | MFSD8 |
|
||||||||||||||||
hsa-miR-200c-3p | ATP6 |
|
||||||||||||||||
hsa-miR-200c-3p | FLNA |
|
||||||||||||||||
hsa-miR-200c-3p | USP22 |
|
||||||||||||||||
hsa-miR-200c-3p | MYB |
|
||||||||||||||||
hsa-miR-200c-3p | ETS1 |
|
||||||||||||||||
hsa-miR-200c-3p | LRP1B |
|
||||||||||||||||
hsa-miR-200c-3p | WIPF1 |
|
||||||||||||||||
hsa-miR-200c-3p | PTPRZ1 |
|
||||||||||||||||
hsa-miR-200c-3p | ELAVL2 |
|
||||||||||||||||
hsa-miR-200c-3p | DUSP1 |
|
||||||||||||||||
hsa-miR-200c-3p | USP25 |
|
||||||||||||||||
hsa-miR-200c-3p | EFNA1 |
|
||||||||||||||||
hsa-miR-200c-3p | RND3 |
|
||||||||||||||||
hsa-miR-200c-3p | DNMT3A |
|
||||||||||||||||
hsa-miR-200c-3p | DNMT3B |
|
||||||||||||||||
hsa-miR-200c-3p | SP1 |
|
||||||||||||||||
hsa-miR-200c-3p | CFL2 |
|
||||||||||||||||
hsa-miR-200c-3p | CDH11 |
|
||||||||||||||||
hsa-miR-200c-3p | SEC23A |
|
||||||||||||||||
hsa-miR-200c-3p | KDR |
|
||||||||||||||||
hsa-miR-200c-3p | HFE |
|
||||||||||||||||
hsa-miR-200c-3p | DLC1 |
|
||||||||||||||||
hsa-miR-200c-3p | ATRX |
|
||||||||||||||||
hsa-miR-200c-3p | ZNF217 |
|
||||||||||||||||
hsa-miR-200c-3p | RASSF8 |
|
||||||||||||||||
hsa-miR-200c-3p | UHRF1BP1 |
|
||||||||||||||||
hsa-miR-200c-3p | ZFHX4 |
|
||||||||||||||||
hsa-miR-200c-3p | ACSL4 |
|
||||||||||||||||
hsa-miR-200c-3p | SHCBP1 |
|
||||||||||||||||
hsa-miR-200c-3p | CAB39 |
|
||||||||||||||||
hsa-miR-200c-3p | NRBP1 |
|
||||||||||||||||
hsa-miR-200c-3p | ATP5G3 |
|
||||||||||||||||
hsa-miR-200c-3p | ZMAT3 |
|
||||||||||||||||
hsa-miR-200c-3p | N4BP2 |
|
||||||||||||||||
hsa-miR-200c-3p | QKI |
|
||||||||||||||||
hsa-miR-200c-3p | TRPS1 |
|
||||||||||||||||
hsa-miR-200c-3p | ANKRD33B |
|
||||||||||||||||
hsa-miR-200c-3p | DNAJB6 |
|
||||||||||||||||
hsa-miR-200c-3p | DDIT4 |
|
||||||||||||||||
hsa-miR-200c-3p | KLHL42 |
|
||||||||||||||||
hsa-miR-200c-3p | NOG |
|
||||||||||||||||
hsa-miR-200c-3p | PARD6B |
|
||||||||||||||||
hsa-miR-200c-3p | DNAJB9 |
|
||||||||||||||||
hsa-miR-200c-3p | HOXA5 |
|
||||||||||||||||
hsa-miR-200c-3p | SHOC2 |
|
||||||||||||||||
hsa-miR-200c-3p | NUFIP2 |
|
||||||||||||||||
hsa-miR-200c-3p | BTC |
|
||||||||||||||||
hsa-miR-200c-3p | ZFPM1 |
|
||||||||||||||||
hsa-miR-200c-3p | PIN1 |
|
||||||||||||||||
hsa-miR-200c-3p | KRAS |
|
||||||||||||||||
hsa-miR-200c-3p | NOTCH1 |
|
||||||||||||||||
hsa-miR-200c-3p | GATA4 |
|
||||||||||||||||
hsa-miR-200c-3p | SUZ12 |
|
||||||||||||||||
hsa-miR-200c-3p | ROCK2 |
|
||||||||||||||||
hsa-miR-200c-3p | UBQLN1 |
|
||||||||||||||||
hsa-miR-200c-3p | E2F3 |
|
||||||||||||||||
hsa-miR-200c-3p | GLI3 |
|
||||||||||||||||
hsa-miR-200c-3p | OSR1 |
|
||||||||||||||||
hsa-miR-200c-3p | PKD1 |
|
||||||||||||||||
hsa-miR-200c-3p | PHF14 |
|
||||||||||||||||
hsa-miR-200c-3p | CDC14B |
|
||||||||||||||||
hsa-miR-200c-3p | ZNF621 |
|
||||||||||||||||
hsa-miR-200c-3p | CACNG8 |
|
||||||||||||||||
hsa-miR-200c-3p | FKBP5 |
|
||||||||||||||||
hsa-miR-200c-3p | M6PR |
|
||||||||||||||||
hsa-miR-200c-3p | KIF13A |
|
||||||||||||||||
hsa-miR-200c-3p | DENND5B |
|
||||||||||||||||
hsa-miR-200c-3p | MALT1 |
|
||||||||||||||||
hsa-miR-200c-3p | CYP1A1 |
|
||||||||||||||||
hsa-miR-200c-3p | SERPINH1 |
|
||||||||||||||||
hsa-miR-200c-3p | TJAP1 |
|
||||||||||||||||
hsa-miR-200c-3p | TPD52L1 |
|
||||||||||||||||
hsa-miR-200c-3p | CASP2 |
|
||||||||||||||||
hsa-miR-200c-3p | AVPR1A |
|
||||||||||||||||
hsa-miR-200c-3p | GPX8 |
|
||||||||||||||||
hsa-miR-200c-3p | ABI2 |
|
||||||||||||||||
hsa-miR-200c-3p | CLEC2D |
|
||||||||||||||||
hsa-miR-200c-3p | UBE2D1 |
|
||||||||||||||||
hsa-miR-200c-3p | TP53INP1 |
|
||||||||||||||||
hsa-miR-200c-3p | ELOC |
|
||||||||||||||||
hsa-miR-200c-3p | PRRG4 |
|
||||||||||||||||
hsa-miR-200c-3p | PLCG1 |
|
||||||||||||||||
hsa-miR-200c-3p | NCOA2 |
|
||||||||||||||||
hsa-miR-200c-3p | JUN |
|
||||||||||||||||
hsa-miR-200c-3p | CELF1 |
|
||||||||||||||||
hsa-miR-200c-3p | CCNT2 |
|
||||||||||||||||
hsa-miR-200c-3p | BAG4 |
|
||||||||||||||||
hsa-miR-200c-3p | TUBB2A |
|
||||||||||||||||
hsa-miR-200c-3p | TCF7L2 |
|
||||||||||||||||
hsa-miR-200c-3p | GPATCH8 |
|
||||||||||||||||
hsa-miR-200c-3p | LMNB1 |
|
||||||||||||||||
hsa-miR-200c-3p | C6orf47 |
|
||||||||||||||||
hsa-miR-200c-3p | TRIM56 |
|
||||||||||||||||
hsa-miR-200c-3p | MAPK7 |
|
||||||||||||||||
hsa-miR-200c-3p | CLPB |
|
||||||||||||||||
hsa-miR-200c-3p | TXNDC16 |
|
||||||||||||||||
hsa-miR-200c-3p | UNC119B |
|
||||||||||||||||
hsa-miR-200c-3p | TMEM119 |
|
||||||||||||||||
hsa-miR-200c-3p | TAF1D |
|
||||||||||||||||
hsa-miR-200c-3p | PAK2 |
|
||||||||||||||||
hsa-miR-200c-3p | NLGN4X |
|
||||||||||||||||
hsa-miR-200c-3p | ERMP1 |
|
||||||||||||||||
hsa-miR-200c-3p | PDPK1 |
|
||||||||||||||||
hsa-miR-200c-3p | CAMSAP2 |
|
||||||||||||||||
hsa-miR-200c-3p | GATA6 |
|
||||||||||||||||
hsa-miR-200c-3p | FRS2 |
|
||||||||||||||||
hsa-miR-200c-3p | CRLF3 |
|
||||||||||||||||
hsa-miR-200c-3p | CDCA4 |
|
||||||||||||||||
hsa-miR-200c-3p | YEATS4 |
|
||||||||||||||||
hsa-miR-200c-3p | MLLT10 |
|
||||||||||||||||
hsa-miR-200c-3p | CDKN1B |
|
||||||||||||||||
hsa-miR-200c-3p | BBX |
|
||||||||||||||||
hsa-miR-200c-3p | ARPC3 |
|
||||||||||||||||
hsa-miR-200c-3p | PSD3 |
|
||||||||||||||||
hsa-miR-200c-3p | ABT1 |
|
||||||||||||||||
hsa-miR-200c-3p | PPM1H |
|
||||||||||||||||
hsa-miR-200c-3p | INO80D |
|
||||||||||||||||
hsa-miR-200c-3p | IGF2 |
|
||||||||||||||||
hsa-miR-200c-3p | FAM216B |
|
||||||||||||||||
hsa-miR-200c-3p | PTPN4 |
|
||||||||||||||||
hsa-miR-200c-3p | TMEM70 |
|
||||||||||||||||
hsa-miR-200c-3p | STX16 |
|
||||||||||||||||
hsa-miR-200c-3p | SEC24A |
|
||||||||||||||||
hsa-miR-200c-3p | MTDH |
|
||||||||||||||||
hsa-miR-200c-3p | IRS1 |
|
||||||||||||||||
hsa-miR-200c-3p | NGRN |
|
||||||||||||||||
hsa-miR-200c-3p | PABPC1 |
|
authors | journal | year | Pubmed link | title | |
---|---|---|---|---|---|
1 | Rebustini et al. | Development | 2012 | 22115756 | miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. |
2 | Cochrane et al. | Mol. Cancer Ther. | 2009 | 19435871 | MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. |
3 | Prislei et al. | BMC Cancer | 2013 | 23394580 | MiR-200c and HuR in ovarian cancer. |
4 | Liu et al. | Biomaterials | 2013 | 23806972 | Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. |
5 | Cochrane et al. | J Oncol | 2010 | 20049172 | Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. |
6 | et al. | None | 21207483 | ||
7 | Lo et al. | J. Pathol. | 2011 | 21294122 | MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. |
8 | Cao et al. | Cancer Cell | 2011 | 21840484 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. |
9 | Shimono et al. | Cell | 2009 | 19665978 | Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. |
10 | Park et al. | Genes Dev. | 2008 | 18381893 | The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. |
11 | Iorio et al. | Cancer Res. | 2007 | 17875710 | MicroRNA signatures in human ovarian cancer. |
12 | Hyun et al. | Cell | 2009 | 20005803 | Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. |
13 | Mees et al. | Int. J. Cancer | 2010 | 19569050 | EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. |
14 | Howe et al. | Breast Cancer Res. | 2011 | 21501518 | Targets of miR-200c mediate suppression of cell motility and anoikis resistance. |
15 | Brabletz et al. | EMBO J. | 2011 | 21224848 | The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. |
16 | Schickel et al. | Mol. Cell | 2010 | 20620960 | miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. |
17 | Sass et al. | BMC Syst Biol | 2011 | 21867514 | MicroRNAs coordinately regulate protein complexes. |
18 | Park et al. | Gynecol. Oncol. | 2012 | 22015043 | The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. |
19 | Senanayake et al. | Carcinogenesis | 2012 | 22431721 | miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. |
20 | Kopp et al. | PLoS ONE | 2012 | 23209748 | miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. |
21 | Adam et al. | Clin. Cancer Res. | 2009 | 19671845 | miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. |
22 | Cai et al. | Graefes Arch. Clin. Exp. Ophthalmol. | 2012 | 22183793 | MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. |
23 | Zhu et al. | Cancer Chemother. Pharmacol. | 2012 | 21993663 | miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. |
24 | Chuang et al. | Endocr. Relat. Cancer | 2012 | 22685266 | miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. |
25 | Panda et al. | Reprod Sci | 2012 | 22569286 | Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. |
26 | Oishi et al. | Hepatology | 2012 | 22707408 | Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. |
27 | Chuang et al. | PLoS ONE | 2014 | 24755559 | miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. |
28 | Hur et al. | Gut | 2013 | 22735571 | MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. |
29 | Lin et al. | J. Cell. Biochem. | 2013 | 22991189 | miR-200c enhances radiosensitivity of human breast cancer cells. |
30 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
31 | Lerner et al. | PLoS ONE | 2012 | 22615771 | MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors. |
32 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
33 | Howe et al. | PLoS ONE | 2012 | 23185507 | miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. |
34 | Luna et al. | PLoS ONE | 2012 | 23272142 | Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. |
35 | Helwak et al. | Cell | 2013 | 23622248 | Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. |
36 | Cesi et al. | Cell Cycle | 2011 | 22101269 | TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. |
37 | Huh et al. | Br. J. Cancer | 2013 | 23807165 | Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. |
38 | Li et al. | Mol. Cancer | 2014 | 24997798 | miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. |
39 | Li et al. | Mol. Carcinog. | 2014 | 23065816 | G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. |
40 | Chang et al. | Pathol. Oncol. Res. | 2014 | 23821457 | MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE. |
41 | Tang et al. | Clin. Cancer Res. | 2013 | 23995857 | miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. |
42 | Luo et al. | J Transl Med | 2013 | 23497265 | A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. |
43 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
44 | Shi et al. | PLoS ONE | 2013 | 24205206 | MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. |
45 | Pacurari et al. | Int. J. Oncol. | 2013 | 23708087 | The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. |
46 | Bai et al. | Int. J. Cancer | 2014 | 24615544 | MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. |
47 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
48 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
49 | Gottwein et al. | Cell Host Microbe | 2011 | 22100165 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
50 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
51 | Li et al. | Int. J. Pediatr. Otorhinolaryngol. | 2013 | 23294929 | MicroRNA expression profiling and target genes study in congenital microtia. |
52 | Yang et al. | J. Clin. Invest. | 2014 | 24762440 | ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. |
53 | Luo et al. | Cancer Res. | 2014 | 24786790 | Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. |
54 | Kopp et al. | Oncotarget | 2014 | 24368337 | The proto-oncogene KRAS is targeted by miR-200c. |
55 | Cama et al. | Acta Neuropathol. | 2013 | 23955600 | Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. |
56 | Huang et al. | Stem Cell Res | 2014 | 24365599 | miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation. |
57 | Peng et al. | Br. J. Cancer | 2013 | 24169343 | Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. |
58 | Sun et al. | Int. J. Cancer | 2015 | 25044403 | MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. |
59 | Tao et al. | Biochim. Biophys. Acta | 2014 | 25017995 | Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development. |
60 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
61 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
62 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
63 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |